Neuregulin 1-induced AKT phosphorylation in monozygotic twins discordant for schizophrenia

Neurochemistry International

Volumn 56, Issue 8, 2010, Pages 906-910

  Seres, Imola ^a,c   Kelemen, Oguz ^b   Benedek, György ^a   Kéri, Szabolcs ^a,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

AKT; Neuregulin 1; Schizophrenia; Twins

Indexed keywords

NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B;

ADULT; ARTICLE; B LYMPHOBLAST; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TWIN DISCORDANCE; WESTERN BLOTTING;

ADULT; CELLS, CULTURED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEUREGULIN-1; NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TWINS, MONOZYGOTIC;

EID: 77952880713     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.03.018     Document Type: Article

References (44)

1. Bruder C.E., Piotrowski A., Gijsbers A.A., Andersson R., Erickson S., de Ståhl T.D., Menzel U., Sandgren J., von Tell D., Poplawski A., Crowley M., Crasto C., Partridge E.C., Tiwari H., Allison D.B., Komorowski J., van Ommen G.J., Boomsma D.I., Pedersen N.L., den Dunnen J.T., Wirdefeldt K., Dumanski J.P. Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am. J. Hum. Genet. 2008, 82:763-771.
2. Bullock W.M., Bolognani F., Botta P., Valenzuela C.F., Perrone-Bizzozero N.I. Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine. Neurochem. Int. 2009, 55(8):775-782.
3. Cannon T.D., Huttunen M.O., Lonnqvist J., Tuulio-Henriksson A., Pirkola T., Glahn D., Finkelstein J., Hietanen M., Kaprio J., Koskenvuo M. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am. J. Hum. Genet. 2000, 67:369-382.
4. Cunha T.M., Roman-Campos D., Lotufo C.M., Duarte H.L., Souza G.R., Verri W.A., Funez M.I., Dias Q.M., Schivo I.R., Domingues A.C., Sachs D., Chiavegatto S., Teixeira M.M., Hothersall J.S., Cruz J.S., Cunha F.Q., Ferreira S.H. Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4442-4447.
5. Donohoe G., Walters J., Morris D.W., Quinn E.M., Judge R., Norton N., Giegling I., Hartmann A.M., Möller H.J., Muglia P., Williams H., Moskvina V., Peel R., O'Donoghue T., Owen M.J., O'Donovan M.C., Gill M., Rujescu D., Corvin A. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Arch. Gen. Psychiatry 2009, 66:1045-1054.
6. Fernandez-Espejo E., Viveros M.P., Núñez L., Ellenbroek B.A., Rodriguez de Fonseca F. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) 2009, 206:531-549.
7. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatrc Press, WA, DC.
8. Fisahn A., Neddens J., Yan L., Buonanno A. Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb. Cortex 2009, 19:612-618.
9. Freund T.F., Katona I. Perisomatic inhibition. Neuron 2007, 56:33-42.
10. Freyberg Z., Ferrando S.J., Javitch J.A. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am. J. Psychiatry 2010, 167:388-396.
11. Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 2008, 34:944-961.
12. Goto Y., Yang C.R., Otani S. Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol. Psychiatry 2010, 67:199-207.
13. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60:132-140.
14. Hirvonen J., van Erp T.G., Huttunen J., Aalto S., Någren K., Huttunen M., Lönnqvist J., Kaprio J., Cannon T.D., Hietala J. Brain dopamine D1 receptors in twins discordant for schizophrenia. Am. J. Psychiatry 2006, 163:1747-1753.
15. Kanakry C.G., Li Z., Nakai Y., Sei Y., Weinberger D.R. Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer. PLoS ONE 2007, 2:e1369.
16. Kato T., Iwamoto K., Kakiuchi C., Kuratomi G., Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol. Psychiatry 2005, 10:622-630.
17. Katona I., Freund T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 2008, 14:923-930.
18. Kéri S., Seres I., Kelemen O., Benedek G. Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions. Neurochem. Int. 2009, 55:606-609.
19. Kéri S., Seres I., Kelemen O., Benedek G. The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals. Schizophr. Bull. 2009, (June). [Epub ahead of print]. 10.1093/schbul/sbp063.
20. Kéri S., Beniczky S., Kelemen O. Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia. Am. J. Psychiatry 2010, 167:444-450.
21. Koros E., Dorner-Ciossek C. The role of glycogen synthase kinase-3beta in schizophrenia. Drug News Perspect. 2007, 20:437-445.
22. Kristofiková Z., Kozmiková I., Hovorková P., Rícný J., Zach P., Majer E., Klaschka J., Rípová D. Lateralization of hippocampal nitric oxide mediator system in people with Alzheimer disease, multi-infarct dementia and schizophrenia. Neurochem. Int. 2008, 53:118-125.
23. Lendeckel U., Kähne T., Ten Have S., Bukowska A., Wolke C., Bogerts B., Keilhoff G., Bernstein H.G. Cathepsin K generates enkephalin from beta-endorphin: a new mechanism with possible relevance for schizophrenia. Neurochem. Int. 2009, 54:410-417.
24. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
25. Matsuzaki S., Tohyama M. Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1). Neurochem. Int. 2007, 52:165-172.
26. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 2008, 9:437-452.
27. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem. Int. 2007, 51:173-184.
28. Nadri C., Belmaker R.H., Agam G. Oxygen restriction of neonate rats elevates neuregulin-1alpha isoform levels: possible relationship to schizophrenia. Neurochem. Int. 2007, 51:447-450.
29. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., Ozaki N., Taguchi T., Tatsumi M., Kamijima K., Straub R.E., Weinberger D.R., Kunugi H., Hashimoto R. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 2004, 13:2699-2708.
30. Owen M.J., Williams H.J., O'Donovan M.C. Schizophrenia genetics: advancing on two fronts. Curr. Opin. Genet. Dev. 2009, 19:266-270.
31. Psychiatric GWAS Consortium Coordinating Committee, Cichon S., Craddock N., Daly M., Faraone S.V., Gejman P.V., Kelsoe J., Lehner T., Levinson D.F., Moran A., Sklar P., Sullivan P.F. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am. J. Psychiatry 2009, 166:540-556.
32. Rhoades H.V., Overall J.E. The semistructured BPRS interview and rating guide. Psychopharmacol. Bull. 1988, 24:101-104.
33. SchizophreniaGene (SZGene) Field Synopsis of Genetic Association Studies of Schizophrenia 2010, SchizophreniaGene. http://www.schizophreniaforum.org/res/sczgene/default.asp.
34. Seeman P., Schwarz J., Chen J.F., Szechtman H., Perreault M., McKnight G.S., Roder J.C., Quirion R., Boksa P., Srivastava L.K., Yanai K., Weinshenker D., Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse 2006, 60:319-346.
35. Sei Y., Ren-Patterson R., Li Z., Tunbridge E.M., Egan M.F., Kolachana B.S., Weinberger D.R. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. Mol. Psychiatry 2007, 12:946-957.
36. Sershen H., Balla A., Aspromonte J.M., Xie S., Cooper T.B., Javitt D.C. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. Neurochem. Int. 2008, 52:119-129.
37. Seshadri S., Kamiya A., Yokota Y., Prikulis I., Kano S., Hayashi-Takagi A., Stanco A., Eom T.Y., Rao S., Ishizuka K., Wong P., Korth C., Anton E.S., Sawa A. Disrupted-in-schizophrenia-1 expression is regulated by {beta}-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5622-5627.
38. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60:1187-1192.
39. Sun J., Jia P., Fanous A.H., Webb B.T., van den Oord E.J., Chen X., Bukszar J., Kendler K.S., Zhao Z. A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics 2009, 25:2595-6602.
40. Thomsen M.S., Hansen H.H., Mikkelsen J.D. Opposite effect of phencyclidine on activity-regulated cytoskeleton-associated protein (Arc) in juvenile and adult limbic rat brain regions. Neurochem. Int. 2010, 56(2):270-275.
41. Trazzi S., Steger M., Mitrugno V.M., Bartesaghi R., Ciani E. CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling. J. Biol. Chem. 2010, 285:10098-10109.
42. Walker E., Downey G., Caspi A. Twin studies of psychopathology: why do the concordance rates vary?. Schizophr. Res. 1991, 5:211-221.
43. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., Yin D.M., Lai C., Terry A.V., Vazdarjanova A., Xiong W.C., Mei L. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1211-1216.
44. Wray N.R., Visscher P.M. Narrowing the boundaries of the genetic architecture of schizophrenia. Schizophr. Bull. 2010, 36:14-23.